dihexa seven orders of magnitude more potent than bdnf There is a compound in human clinical trials for Alzheimer’s and Parkinson’s right now that most physicians treating those conditions have never once mentioned to a patient., It is called Dihexa., It Frontiers | Modulation of Serum

BPC-157, short for Body Protection Compound 157, is a synthetic peptide made up of 15 amino acids

Interestingly, a post-hoc analysis of the Prediabetes Lifestyle Intervention Study (PLIS) suggested that patients achieving prediabetes remission differed from non-responders in improvement in whole body insulin sensitivity, visceral adipose tissue (VAT) and intrahepatic fat rather than insulin secretion upon a similar weight loss 76

Both peptides can be given once a week, which makes counting easier than with daily therapies

Research published in the Journal of Physiology and Pharmacology indicates BPC-157 enhances angiogenesisthe formation of new blood vesselswhich delivers oxygen and nutrients to damaged tissues

The IUPAC designation specifies stereochemical configurations at multiple chiral centers ((2S,3S) notation)

Shelf life: 24 months from the manufacturing date